Trial intelligence / Profile preview

Aurstat Anti-Itch Hydrogel for Atopic Dermatitis Pruritus

NCT01905631Phase 2Completed

Sponsor
Center for Clinical and Cosmetic Research
Start
Jul 2013
Primary completion
Sep 2013
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of atopiclair in atopic dermatitis (AD), sponsored by Center for Clinical and Cosmetic Research. Started Jul 2013; status: completed.

02

Drugs

atopiclair
03

Conditions

atopic dermatitis (AD)

Beyond the preview

Go deeper on NCT01905631.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01905631.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call